These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Bhatt DL; Topol EJ JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650 [TBL] [Abstract][Full Text] [Related]
4. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective. Dyke CM Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236 [TBL] [Abstract][Full Text] [Related]
5. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P; Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315 [TBL] [Abstract][Full Text] [Related]
6. Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy. Wu KK; Willerson JT Circulation; 2001 May; 103(21):2528-30. PubMed ID: 11382717 [No Abstract] [Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibitors in patients with renal insufficiency undergoing percutaneous coronary intervention. Anderson JR; Riding D Cardiol Rev; 2008; 16(4):213-8. PubMed ID: 18562812 [TBL] [Abstract][Full Text] [Related]
8. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Adgey AA Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L; N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425 [TBL] [Abstract][Full Text] [Related]
10. Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. Casterella PJ; Revenaugh JR; Burke JL; Pearson RR; Bair TL; May HT; Horne B; Anderson JL; Muhlestein JB J Invasive Cardiol; 2008 Mar; 20(3):94-8. PubMed ID: 18316822 [TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes. Vernon SM Cardiol Clin; 2001 May; 19(2):235-52, vi. PubMed ID: 11407108 [TBL] [Abstract][Full Text] [Related]
13. Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use. Pang JT; Fort S; Della Siega A; Cohen EA J Card Surg; 2002; 17(5):425-31. PubMed ID: 12630543 [TBL] [Abstract][Full Text] [Related]
14. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes. Koller CF Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974 [TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. Dasgupta H; Blankenship JC; Wood GC; Frey CM; Demko SL; Menapace FJ Am Heart J; 2000 Aug; 140(2):206-11. PubMed ID: 10925331 [TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. Tcheng JE Am J Cardiol; 1996 Aug; 78(3A):35-40. PubMed ID: 8751845 [TBL] [Abstract][Full Text] [Related]
18. [Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease]. Patti G; Fossati C; Manzoli A; D'Ambrosio A; Abbate A; Montesanti R; Di Sciascio G Clin Ter; 2000; 151(4):301-6. PubMed ID: 11107681 [TBL] [Abstract][Full Text] [Related]
19. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors. Dobesh PP; Latham KA Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642 [TBL] [Abstract][Full Text] [Related]
20. Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy. Juran NB Am Heart J; 1999 Oct; 138(4 Pt 2):297-306. PubMed ID: 10502235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]